You can add items from the left menu by dragging them here.

Advair, a variety of salmeterol (Serevent) and fluticasone (Flovent) is one of the best selling drugs on the planet. Salmeterol
can be a bronchodilator which dilates the airways and fluticasone is really a steroid which reduces airway inflammation. However, the
drug comes under scrutiny as a result of recent are convinced that Advair could actually increase asthma deaths. The producer
GlaxoSmithKline, however, has rejected the findings and calls this content extremely irresponsible and full of inaccuracies.

Forbes magazinehad in an article on 6th April, reported that "growing evidence implies that half the normal commission of patients--perhaps 4,000
people a year, by one doctor's estimate--may be dying due to Advair or its Serevent component" purchase differin online.


It quotes Dr. Shelley Salpeter, a clinical professor of drugs at Stanford University who argues who says bothAdvair and Serevent should be recalled. Dr. Shelley reviewed the outcomes of 19 previous trials of Serevent-style drugs and discovered
that patients have twice the pace of asthma hospitalizations, twice the rate of life-threatening asthma and four times numerous deaths
as patients that are but not on those drugs.

Apparently, Advair and Serevent cause four of each andevery five asthma-related deaths each year. "These drugs make asthma worse," Dr. Shelley says. By some estimates, asthma kills roughly
5,000 Americans per year. This extrapolates to 4000 asthma deaths linked to these drugs.

In response, Glaxo saysits detractors are exaggerating the hazards. "The safety and efficacy of Advair are exceedingly well-established with regulators and physicians around
the globe," A Glaxo spokeswoman said. "The data we have now are inconclusive," says Kathy A. Rickard, a Glaxo v
. p . , echoing early responses by Wyeth about its Redux diet drug and Merck & Co. about its
Vioxx painkiller.

Last month GlaxoSmithKline had reached a contract with all the U. S. regulator to update Advair'slabel once you get your warning advising doctors to limit the application of the drug to patients who don't make
use of other asthma drugs, or whorrrre severe cases.